- Notes on the Contributors
- Methods in Bioethics
- The Way We Reason Now: Reflective Equilibrium in Bioethics
- Mental Disorder, Moral Agency, and the Self
- ‘Reinventing’ the Rule of Double Effect
- Policy‐Making in Pluralistic Societies
- Tiers Without Tears: the Ethics of a Two‐Tier Health Care System
- Justice and the Elderly
- Organ Transplantation
- For Dignity or Money: Feminists on the Commodification of Women's Reproductive Labour
- The Definition of Death
- The Aging Society and the Expansion of Senility: Biotechnological and Treatment Goals
- Death is a Punch in the Jaw: Life‐Extension and its Discontents
- Precedent Autonomy, Advance Directives, and End‐of‐Life Care
- Physician‐Assisted Death: the State of the Debate
- Abortion Revisited
- Moral Status, Moral Value, and Human Embryos: Implications for Stem Cell Research
- Therapeutic Cloning: Politics and Policy
- Population Genetic Research and Screening: Conceptual and Ethical Issues
- Genetic Interventions and The Ethics of Enhancement of Human Beings
- Pharmacogenomics: Ethical and Regulatory Issues
- Clinical Equipoise: Foundational Requirement or Fundamental Error?
- Research on Cognitively Impaired Adults
- Research in Developing Countries
- Animal Experimentation
- The Implications of Public Health for Bioethics
- Global Health
- Bioethics and Bioterrorism
Abstract and Keywords
Understanding the ethics of enhancement begins with getting clear about the concept, as well as the factors likely to move people to pursue biomedical enhancement. This article first considers the usefulness of the distinction between therapy and enhancement for understanding the ethics of enhancement. Once the conceptual underbrush has been cleared away, we can move on to ethics. The next section examines critically a number of arguments that have been offered to defend biomedical enhancement, or, at least, to claim that efforts to deter it are either ethically or practically mistaken. Finally, the article considers a set of arguments that take the ethics of enhancement to be a serious matter and that gives reasons to question whether some biomedical enhancements, for some purposes, may be ethically suspect.
Thomas H. Murray is President of the Hastings Center, Garrison, NY. He has written or edited many books including The Worth of a Child (University of California Press, 1996), Cultures of Caregiving (with C. Levine; Johns Hopkins University Press, 2004), Genetic Ties and the Family (with M. Rothstein, G. Kaebnick, and M. A. Majumder; Johns Hopkins University Press, 2005), The Encyclopedia of Ethical, Legal, and Policy Issues in Biotechnology (with M. Mehlman; John Wiley, 2000), and Feeling Good and Doing Better: Ethics and Nontherapeutic Drug Use (Humana Press, 1984). He is Chair of the World Anti‐Doping Agency's Ethical Issues Review Panel.
Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.